Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

PLI's ERISA 2024: The Evolving World

Summary

Speakers

Alison V. Douglass

Related Content

Minding the Store: Unanticipated ESG Issues Affecting ERISA Fiduciary Supervision

The U.S. Department Of Labor’s New Definition of Fiduciary Investment Advice Is Finalized (Again)

A Token of Appreciation: Cryptoassets and Employee Incentives — a UK Tax Primer

DOL Issues New Rule Raising Minimum Salary Thresholds for Overtime Exemptions

The Department of Labor Finalizes Changes to the QPAM Exemption – A Favored Management Tool Gets Less User-Friendly

Deadline Approaching for Reporting 2023 ISO Exercises and ESPP Transfers

Rushing to Chaos: The U.S. Department of Labor’s Well-Intentioned, Yet Unworkable Proposal to Redefine Fiduciary Investment Advice

ERISA Litigation Update

Envato Officially Acquired By Shutterstock

Rapport Therapeutics Completes $174.4 Millon Initial Public Offering and Concurrent Private Placement

The Legal 500 US 2024 Recognizes 44 Goodwin Practices and 186 Lawyers

Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service

Akili Interactive to Be Acquired by Virtual Therapeutics

Human Immunology Biosciences to be Acquired by Biogen For $1.15 Billion Upfront and up to $650 Million in Potential Milestone Payments

Proteologix to be Acquired by Johnson & Johnson For $850 Million

Royalty Pharma To Acquire Royalty Interest In ImmuNext’s Frexalimab

ERISA & Executive Compensation